Call Options Transactions Made in Q3 2024 in Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the institutional ownership of Terns Pharmaceuticals, Inc. (TERN) during Q3 2024. The information is specifically focused on institutions that hold call options of Terns Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
96KNew |
$623K - $1.04M
|
96K
$400K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
65.5K+ 102.5% |
$425K - $707K
|
129K
$540K
|
|
|
Nov 15, 2024
Q3 2024
|
Barclays PLC
London, X0 |
BUY
|
CALL |
34.4KNew |
$223K - $372K
|
34.4K
$143K
|
|
|
Nov 13, 2024
Q3 2024
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
11.1KNew |
$72K - $120K
|
11.1K
$46.3K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-9.8K- 3.79% |
$63.6K - $106K
|
249K
$1.04M
|
|
|
Nov 13, 2024
Q3 2024
|
Myda Advisors LLC
Inwood, NY |
SELL
|
CALL |
-30K- 75.0% |
$195K - $324K
|
10K
$41.7K
|